Business

Innate Pharma Announces Conference Call and Webcast for Full Year 2025 Financial Results

MARSEILLE, France, March 19, 2026--Innate Pharma announces conference call and webcast for full year 2025 financial results

articleInnate Pharma Sa Class AMarch 19, 20263/company/innate-pharma-sa-class-a/news/innate-pharma-announces-conference-call-and-webcast-for-full-year-2025-financial-results-1
Innate Pharma Announces Conference Call and Webcast for Full Year 2025 Financial Results

About this update from Innate Pharma Sa Class A

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/97154c72b05549b93a2f3a72ad99c061"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/J9zaDGhcQ423.lYbHJu0VA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MA--/https://media.zenfs.com/en/business-wire.com/97154c72b05549b93a2f3a72ad99c061","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/z_3946dTjr9sdttwOQJLAA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0/https://media.zenfs.com/en/business-wire.com/97154c72b05549b93a2f3a72ad99c061","width":1024,"height":512}},"lazy":false},{"type":"text","content":"MARSEILLE, France, March 19, 2026--(BUSINESS WIRE)--Regulatory News:","length":68,"tagName":"p"},{"type":"text","content":"Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), today announces that the Company will hold a conference call on Thursday, March 26, 2026 at 2 p.m. CET / 9 a.m. EDT, following the release of its financial results for the full year ending December 31, 2025.","length":309,"tagName":"p"},{"type":"text","content":"Participants during the call will be:","length":37,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Jonathan Dickinson, Chief Executive Officer","length":43,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Sonia Quaratino, Executive Vice President, Chief Medical Officer","length":64,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Yannis Morel, Executive Vice President, Chief Operating Officer","length":63,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Stéphanie Cornen, Vice President, Investor Relations, Communication and Commercial Strategy","length":91,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Frédéric Lombard, Senior Vice President, Chief Financial Officer","length":64,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":325,"olType":false},{"type":"text","content":"Details for the Virtual Event","length":29,"tagName":"p"},{"type":"text","content":"The live webcast will be available at the following link:https://events.q4inc.com/attendee/704730270","length":101,"tagName":"p","attribs":{}},{"type":"text","content":"Participa...

More updates from Innate Pharma Sa Class A

Euronext ParisInnate PharmaInnate Pharma SAChief Medical OfficerExecutive Vice PresidentJonathan DickinsonChief Executive OfficerCompanythe CompanyIPHNasdaq